Patient-controlled Analgesia Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Patient-controlled Analgesia Pumps Market Analysis

The patient-controlled analgesia (PCA) pump market is expected to register a CAGR of 5.2% over the forecast period.

The healthcare system witnessed enormous challenges as a result of the COVID-19 pandemic. During the first phase of COVID-19, the expansion of the patient-controlled analgesia pump market was significantly constrained for several uncertain reasons. However, there is an increasing occurrence of chronic pain in patients who recovered from COVID-19 infection. For instance, as per the Current Pain and Headache Reports in March 2022, the vaccination for COVID-19 in the United States may be reducing the number of new SARS-CoV-2 cases, but the population of those suffering from the virus's long-term symptoms is growing. One of these long-term side effects includes chronic pain syndromes. Hence, to manage the chronic pain of COVID-19-recovered patients, there is a need for patient-controlled analgesia pumps, which help the patient control their pain. This is expected to positively impact the market over the forecast period.

The major factors attributing to the market's growth are the increasing prevalence of chronic pain diseases such as arthritis, cancer, and fibromyalgia, along with the technological advancements with enhanced safety features in the PCA pumps. Fibromyalgia is a condition that causes pain all over the body, also called widespread pain. The increase in the prevalence of fibromyalgia helps the growth of the patient-controlled analgesia pump market. For instance, according to the updated data from CDC in May 2022, about 4 million US citizens, or 2% of all adults, suffer from fibromyalgia. Although there is no known cause for fibromyalgia, it is treatable and manageable with various pain management methods, one of which is a patient-controlled analgesia pump. Hence a significant burden of chronic pain diseases like fibromyalgia increases the usage of patient-controlled analgesia pumps and drives the market's growth over the study period.

The recent product launches and approvals by the regulatory authorities focusing on patient-controlled analgesia pumps are expected to aid in the market's growth, as these approvals will increase product availability and competition in the market. For instance, in April 2021, Becton, Dickinson, and Company submitted a 510(k) premarket notification to the US FDA for the BD Alaris System. The system allows clinicians to deliver pain medications and fluids through a single integrated platform that includes large-volume pumps and syringe pumps for adult, pediatric and neonatal patients. Thus, the large population affected by chronic pain-causing diseases and the increasing product approvals are expected to add to the growth of the studied market over the forecast period. However, the lack of awareness resulting in patient medication errors and the stringent regulatory framework and associated product recalls are likely to slow down the market growth over the forecast period.

Patient-controlled Analgesia Pumps Market Trends

This section covers the major market trends shaping the Patient-controlled Analgesia Pumps Market according to our research experts:

Oncology is Expected to Hold the Major Market Share in the Market Over the Forecast Period

Patient-controlled Analgesia Pumps Industry Segmentation

As per the scope of the report, patient-controlled analgesia (PCA) pumps are devices that can help patients control their pain by regulating the amount of medication used in managing pain. These PCA pumps contain a pain medication syringe that delivers a small amount of prescribed medication at a constant flow rate to the patient. The patient-controlled analgesia pumps market is segmented by product type (PCA pumps and pump accessories), application (oncology, diabetes, neonatology, and other applications), end users (hospital, ambulatory surgical centers, and home-care settings), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends of 17 countries across major regions globally. The market sizes and forecasts are provided in terms of value (USD million) for all the above segments.